EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Chronic kidney disease-induced muscle atrophy: Molecular mechanisms and promising therapies

Kexin Wang, Qingyuan Liu, Mingyu Tang, Guangdong Qi, Chong Qiu, Yan Huang, Weiran Yu, Wei Wang, Hualin Sun, Xuejun Ni, Yuntian Shen, Xingxing Fang

Biochemical Pharmacology · 2023-02 · 208 · 115407

DOI: 10.1016/j.bcp.2022.115407 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochemical Pharmacology, 2023-02. Verfasst von Kexin Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, the Second Affiliated Hospital of Nantong University, Nantong, Jiangsu Province 226001, PR China; Key Laboratory of Neurore…. Hauptthemen laut MEDLINE: Quality of Life, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 128-mal zitiert (Crossref) und nennt 156 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Nantong University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic kidney disease (CKD) is a high-risk chronic catabolic disease due to its high morbidity and mortality. CKD is accompanied by many complications, leading to a poor quality of life, and serious complications may even threaten the life of CKD patients. Muscle atrophy is a common complication of CKD. Muscle atrophy and sarcopenia in CKD patients have complex pathways that are related to multiple mechanisms and related factors. This review not only discusses the mechanisms by which inflammation, oxidative stress, mitochondrial dysfunction promote CKD-induced muscle atrophy but also explores other CKD-related complications, such as metabolic acidosis, vitamin D deficiency, anorexia, and excess angiotensin II, as well as other related factors that play a role in CKD muscle atrophy, such as insulin resistance, hormones, hemodialysis, uremic toxins, intestinal flora imbalance, and miRNA. We highlight potential treatments and drugs that can effectively treat CKD-induced muscle atrophy in terms of complication treatment, nutritional supplementation, physical exercise, and drug intervention, thereby helping to improve the prognosis and quality of life of CKD patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeRenal Insufficiency, ChronicHumansMuscular AtrophyChronic DiseaseOxidative Stress

Stichwörter der Autor:innen

Chronic kidney diseaseInflammationMolecular mechanismsMuscle atrophyTherapy

Autor:innen und Institutionen

  • Department of Nephrology, the Second Affiliated Hospital of Nantong University, Nantong, Jiangsu Province 226001, PR China; Key Laboratory of Neuroregeneration of Jiangsu and Ministry of Education, Co-Innovation Center…
  • Department of Endocrinology, Binhai County People's Hospital, Yancheng, Jiangsu Province 224500, PR China.
  • Xinglin College, Nantong University, Nantong, Jiangsu Province 226001, PR China.
  • Department of Clinical Medicine, Medical College, Nantong University, Nantong, Jiangsu Province 226001, PR China.
  • Key Laboratory of Neuroregeneration of Jiangsu and Ministry of Education, Co-Innovation Center of Neuroregeneration, NMPA Key Laboratory for Research and Evaluation of Tissue Engineering Technology Products, Jiangsu Cli…
  • Department of Ultrasound Medicine, Affiliated Hospital of Nantong University, Nantong, Jiangsu Province 226001, PR China. Electronic address: lily038@ntu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangsu Province
  • Nantong University
  • Nantong City Science and Technology Bureau
  • Priority Academic Program Development of Jiangsu Higher Education Institutions

Zitieren

APA

Wang, K., Liu, Q., Tang, M., Qi, G., Qiu, C., Huang, Y., Yu, W., Wang, W., Sun, H., Ni, X., Shen, Y., & Fang, X. (2023). Chronic kidney disease-induced muscle atrophy: Molecular mechanisms and promising therapies. Biochemical Pharmacology, 208, 115407. https://doi.org/10.1016/j.bcp.2022.115407

Vancouver

Wang K, Liu Q, Tang M, Qi G, Qiu C, Huang Y, et al. Chronic kidney disease-induced muscle atrophy: Molecular mechanisms and promising therapies. Biochemical Pharmacology. 2023;208:115407. doi:10.1016/j.bcp.2022.115407

BibTeX
@article{Wang2023,
  author = {Wang, Kexin and Liu, Qingyuan and Tang, Mingyu and Qi, Guangdong and Qiu, Chong and Huang, Yan and Yu, Weiran and Wang, Wei and Sun, Hualin and Ni, Xuejun and Shen, Yuntian and Fang, Xingxing},
  title = {Chronic kidney disease-induced muscle atrophy: Molecular mechanisms and promising therapies},
  journal = {Biochemical Pharmacology},
  year = {2023},
  volume = {208},
  pages = {115407},
  doi = {10.1016/j.bcp.2022.115407}
}
Kostenlos starten →